Status:
COMPLETED
Retrospective Study of Long-term Survival and Related Factors Among Kidney Transplant Recipients in China
Lead Sponsor:
Novartis
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-75 years
Brief Summary
The primary objective of this study is to evaluate graft survival and recipient survival among kidney transplant recipients in China, and also to analyze possible factors related to patient and graft ...
Detailed Description
Renal transplantation is the choice for patients with end-stage renal disease. In the past two decades, progress in surgical procedure, medical care, and immunosuppression have significantly improved ...
Eligibility Criteria
Inclusion
- Kidney transplant recipients
- Received a transplant from Jan 1,1995 to Dec 31, 2007, only including those with living donor grafts
- Age: 18-75 years
Exclusion
- Multiple-organ transplant recipients
- Patients records with missing information in 12 months post-transplantation
- Patients who did not have the information regarding their maintenance immunosuppressive therapy
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT01796639
Start Date
April 1 2012
End Date
August 1 2013
Last Update
June 18 2014
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
The 309th Hospital of Chinese People's Liberation Army
Beijing, Beijing Municipality, China, 100000
2
Beijing Chaoyang Hospital
Beijing, Beijing Municipality, China, 100020
3
Peking University First Hospital
Beijing, Beijing Municipality, China, 100034
4
Beijing Friendship Hospital
Beijing, Beijing Municipality, China, 100050